ENZB logo

Enzo Biochem, Inc. Stock Price

OTCPK:ENZB Community·US$36.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ENZB Share Price Performance

US$0.70
0.04 (6.21%)
US$0.70
0.04 (6.21%)
Price US$0.70

ENZB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet unattractive dividend payer.

2 Risks
1 Reward

Enzo Biochem, Inc. Key Details

US$27.5m

Revenue

US$15.7m

Cost of Revenue

US$11.8m

Gross Profit

US$19.6m

Other Expenses

-US$7.8m

Earnings

Last Reported Earnings
Apr 30, 2025
Next Reporting Earnings
n/a
-0.15
42.83%
-28.54%
0.5%
View Full Analysis

About ENZB

Founded
1976
Employees
131
CEO
Kara Cannon
WebsiteView website
www.enzo.com

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Recent ENZB News & Updates

Recent updates

No updates